Literature DB >> 29621037

"No-Go Considerations" for In Situ Simulation Safety.

Komal Bajaj1, Anjoinette Minors, Katie Walker, Michael Meguerdichian, Mary Patterson.   

Abstract

STATEMENT: In situ simulation is the practice of simulation in the actual clinical environment and has demonstrated utility in the assessment of system processes, identification of latent safety threats, and improvement in teamwork and communication. Nonetheless, performing simulated events in a real patient care setting poses potential risks to patient and staff safety. One integral aspect of a comprehensive approach to ensure the safety of in situ simulation includes the identification and establishment of "no-go considerations," that is, key decision-making considerations under which in situ simulations should be canceled, postponed, moved to another area, or rescheduled. These considerations should be modified and adjusted to specific clinical units. This article provides a framework of key essentials in developing no-go considerations.

Entities:  

Mesh:

Year:  2018        PMID: 29621037     DOI: 10.1097/SIH.0000000000000301

Source DB:  PubMed          Journal:  Simul Healthc        ISSN: 1559-2332            Impact factor:   1.929


  11 in total

1.  In Situ Simulation Enables Operating Room Agility in the COVID-19 Pandemic.

Authors:  Sharon L Muret-Wagstaff; Jeremy S Collins; Darlene L Mashman; Snehal G Patel; Kate Pettorini; Seth A Rosen; Virginia O Shaffer; Michele L Sumler; John F Sweeney; Jyotimay Sharma
Journal:  Ann Surg       Date:  2020-05-20       Impact factor: 12.969

2.  Hospital-wide cardiac arrest in situ simulation to identify and mitigate latent safety threats.

Authors:  Suzanne K Bentley; Alexander Meshel; Lorraine Boehm; Barbara Dilos; Mamie McIndoe; Rachel Carroll-Bennett; Alfredo J Astua; Lillian Wong; Colleen Smith; Laura Iavicoli; Julia LaMonica; Tania Lopez; Jose Quitain; Guirlene Dube; Alex F Manini; Joseph Halbach; Michael Meguerdichian; Komal Bajaj
Journal:  Adv Simul (Lond)       Date:  2022-05-21

3.  Simulation Safety First: An Imperative.

Authors:  Daniel Raemer; Alexander Hannenberg; Ann Mullen
Journal:  Simul Healthc       Date:  2018-12       Impact factor: 1.929

4.  Translational simulation: from description to action.

Authors:  Christopher Peter Nickson; Andrew Petrosoniak; Stephanie Barwick; Victoria Brazil
Journal:  Adv Simul (Lond)       Date:  2021-03-04

5.  "A debriefer must be neutral" and other debriefing myths: a systemic inquiry-based qualitative study of taken-for-granted beliefs about clinical post-event debriefing.

Authors:  Julia Carolin Seelandt; Katie Walker; Michaela Kolbe
Journal:  Adv Simul (Lond)       Date:  2021-03-04

6.  Evaluation of the feasibility and impacts of in situ simulation in emergency medicine-a mixed-method study protocol.

Authors:  Jennifer Truchot; Valérie Boucher; Éliane Raymond-Dufresne; Christian Malo; Éric Brassard; Jean Marcotte; Guillaume Martel; Geneviève Côté; Christian Garneau; Gino Bouchard; Marcel Emond
Journal:  BMJ Open       Date:  2021-03-04       Impact factor: 2.692

7.  Developing a simulation safety policy for translational simulation programs in healthcare.

Authors:  Victoria Brazil; Clare Scott; Jack Matulich; Brenton Shanahan
Journal:  Adv Simul (Lond)       Date:  2022-01-24

8.  Use of Virtually Facilitated Simulation to Improve COVID-19 Preparedness in Rural and Remote Canada.

Authors:  Sharon Reece; Monika Johnson; Kristin Simard; Annamaria Mundell; Nadine Terpstra; Theresa Cronin; Mirette Dubé; Alyshah Kaba; Vincent Grant
Journal:  Clin Simul Nurs       Date:  2021-02-13       Impact factor: 2.856

9.  The unexpected and the non-fitting - considering the edges of simulation as social practice.

Authors:  Peter Dieckmann
Journal:  Adv Simul (Lond)       Date:  2020-02-05

10.  In Situ Simulation Enables Operating Room Agility in the COVID-19 Pandemic.

Authors:  Sharon L Muret-Wagstaff; Jeremy S Collins; Darlene L Mashman; Snehal G Patel; Kate Pettorini; Seth A Rosen; Virginia O Shaffer; Michele L Sumler; John F Sweeney; Jyotirmay Sharma
Journal:  Ann Surg       Date:  2020-08       Impact factor: 13.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.